» Articles » PMID: 29992786

Neurocognitive Disorders and Sleep in Children with Primary Ciliary Dyskinesia

Overview
Date 2018 Jul 12
PMID 29992786
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Primary ciliary dyskinesia (PCD) patients have higher incidence of sleep disordered breathing which lead neurocognitive impairments such as attention-deficit/hyperactivity disorder (ADHD). It may effect academic performance of children and may cause impairment in emotional relationships. This study aim to evaluate hyperactivity and attention deficiency in PCD patients and investigate the relationship between sleep and hyperactivity and attention deficiency in PCD patients.

Method: Fifteen PCD patients aged 8-18 years and 31 age-matched healthy controls were compared. Ear, nose, and throat examination and home sleep testing were performed in PCD patients. Pediatric sleep questionnaire, Conners' Parents and Teacher scale and Stroop test were applied in both groups in order to investigate the relation between sleep disordered breathing and ADHD in PCD children.

Results: PCD patients had chronic rhinosinusitis (100%), tonsillar hypertrophy (80%) and adenoidal hypertrophy (60%). FEF25-75 was low in pulmonary function test. Sixty percent of the PCD patients had mild obstructive sleep apnea syndrome in home sleep testing. Mean AHI was 1.54 ± 0.27. Compared with the controls PCD patients had higher PSQ scores. Hyperactivity scores on Conners' Parents scale and inattention findings in Stroop test were higher in PCD patients than the healthy controls (P < 0.05).

Conclusion: Most of PCD children had mild obstructive sleep apnea syndrome. Hyperactivity and inattention findings were higher in PCD patients. Sleep disordered breathing assessment should be a routine part of PCD patients management and these patients should be carefully monitored in terms of hyperactivity and inattention.

Citing Articles

A Pilot Study of Primary Ciliary Dyskinesia: Sleep-Related Disorders and Neuropsychiatric Comorbidities.

Cardona-Quinones R, Ramirez-Rivera E, Alvarez-Torres E, Salem-Hernandez S, Vargas-Perez N, De Jesus-Rojas W J Clin Med. 2025; 14(4).

PMID: 40004884 PMC: 11856783. DOI: 10.3390/jcm14041353.


Ear and upper airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Alexandru M, Veil R, Rubbo B, Goutaki M, Kim S, Lam Y Eur Respir Rev. 2023; 32(169).

PMID: 37437912 PMC: 10336562. DOI: 10.1183/16000617.0200-2022.


Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Gahleitner F, Thompson J, Jackson C, Hueppe J, Behan L, Dehlink E ERJ Open Res. 2021; 7(4).

PMID: 34853782 PMC: 8628193. DOI: 10.1183/23120541.00320-2021.


Sleep disturbances in children with cystic fibrosis, primary ciliary dyskinesia and typically developing children during COVID-19 pandemic.

Sismanlar Eyuboglu T, Tana Aslan A, Ramasli Gursoy T, Asfuroglu P, Soysal A, Yapar D J Paediatr Child Health. 2021; 57(10):1605-1611.

PMID: 34004018 PMC: 8242396. DOI: 10.1111/jpc.15553.


OSA and Neurocognitive Impairment in Children With Congenital Heart Disease.

Combs D, Edgin J, Klewer S, Barber B, Morgan W, Hsu C Chest. 2020; 158(3):1208-1217.

PMID: 32222588 PMC: 7478226. DOI: 10.1016/j.chest.2020.03.021.